As Olainfarm in brief
As Olainfarm is a listed company in the Pharmaceutical industry, based in Latvia. It was founded in 1991. Its last known market value was $124 M (January 2021); there is no current figure. In its latest reported year it had sales of $119 M and a net profit of $19 M, about 16 cents of profit for every dollar of sales. It employs about 1,054 people. Its shares trade under the symbol UU4.F (Frankfurt).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
About As Olainfarm
JSC Olpha (formerly JSC Olainfarm) is a Latvian pharmaceutical company and drug manufacturer. In June 2024, Olainfarm announced a rebranding to Olpha.
The company traces its origins to the Olaine Chemical-Pharmaceutical Plant. Its first synthesis of furagin was carried out on 10 October 1972, a date the company identifies as the start of its operations under the name Olaines ķīmiski-farmaceitiskā rūpnīca.
Olainfarm produces over 60 final dosage forms, 25 active pharmaceutical ingredients and 20 intermediates. Their key areas of specialization in final dosage forms include neurology (cholinesterase inhibitors, anxiolytics, psychostimulants, nootropics), cardiology (antiarrhythmics, energy metabolism enhancers), infectology (original nitrofurantoine derivatives and antivirals) and allergology (fast acting antihistamines).
From Wikipedia: read the full article · text available under CC BY-SA 4.0
As Olainfarm timeline
- 1991
- 🏁Founded
Events of As Olainfarm from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Latvia: #3 (Jan 2020) · #3 (Jan 2021)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 16.0%
- Operating margin
- —
- Return on equity
- —
- Liabilities / assets
- —
- Revenue per employee
- $113 K
- Profit per employee
- $18 K
Annual results
- Revenue
- $119 M
- Operating income
- —
- Net income
- $19 M
Fiscal year 2022 · source: Wikidata (cited)
Balance sheet
- Total assets
- $209 M
- Total liabilities
- —
- Total equity
- —
Fiscal year 2022
As Olainfarm scorecard#
Passes 1 of the 1 checks that could be worked out. Fiscal year 2022.
Valuationnot known
Growthnot known
Profitability1 of 1
Financial healthnot known
Shareholder returnsnot known
Worked out from the statements as filed (wikidata), the medians of Pharmaceutical, the 10-year Treasury yield of Nov 20, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
How As Olainfarm compares in Pharmaceutical
- Revenue$119 M · higher than 23% of 329
- Net margin16.0% · higher than 75% of 315
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| As Olainfarm🇱🇻 | $124 M | — | 16.0% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
How current the figures are
- Market cap:
- Jan 1, 2021 (last known)
- Annual results:
- Fiscal year 2022
- Balance sheet:
- Fiscal year 2022
- Employees:
- 2022
- Profile updated:
- Nov 4, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at As Olainfarm? Verify and update this profile — free
Show As Olainfarm's ranking on your website Get the badge
The badge updates itself as the ranking changes.